Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned

Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned

The COVID-19 pandemic has created unprecedented hurdles to the delivery of care to patients with cancer. Patients with hematologic malignancies appear to have a greater risk of SARS-CoV-2 infection and severe disease due to myelosuppression and lymphopenia. The first challenge, therefore, is how to...

Full description

Bibliographic Details
Main Authors: Alessandro Isidori, Laurence de Leval, Usama Gergis, Pellegrino Musto, Pierluigi Porcu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
SARS-CoV-2
hematologic malignancies
COVID-19
lymphoma
myeloma
leukemia
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01439/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01439/full

Similar Items